NCT01457495: Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly |
|
|
| Completed | 2 | 312 | NA | DTPa-HBV-IPV/Hib (Infanrix-hexa™), DTPa-IPV/Hib (Infanrix-IPV/Hib™), HBV (Engerix™-B) | GlaxoSmithKline | Hepatitis B, Diphtheria, Haemophilus Influenzae Type b (Hib), Poliomyelitis, Pertussis, Tetanus | 09/99 | 09/99 | | |
NCT00831311: Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants |
|
|
| Completed | 2 | 624 | RoW | DTaP-IPV-HB-PRP~T, DTaP-IPV//PRP~T combined vaccine & Recombinant hep B vaccine, PENTAXIM™, ENGERIX B® PEDIATRICO | Sanofi Pasteur, a Sanofi Company | Diphtheria, Tetanus, Pertussis, Haemophilus Influenzae Type b, Poliomyelitis | 11/05 | 03/07 | | |
